33 min listen
Unavailable
Currently unavailable
TWiV 707: COVID-19 clinical update #45 with Dr. Daniel Griffin
Currently unavailable
TWiV 707: COVID-19 clinical update #45 with Dr. Daniel Griffin
ratings:
Length:
40 minutes
Released:
Jan 16, 2021
Format:
Podcast episode
Description
In COVID-19 clinical update #45, Daniel Griffin discusses J&J Ad26 vaccine results, reactogenicity after the second dose of mRNA vaccines, expansion of vaccine eligibility, and the finding that encephalitis after SARS-CoV-2 infection is a cytokine release syndrome. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode J&J Ad26 vaccine phase 1/2 results (NEJM) SARS-CoV-2 encephalitis is a cytokine release syndrome (CID) Letters read on TWiV 707 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
Released:
Jan 16, 2021
Format:
Podcast episode
Titles in the series (100)
TWiV 1030: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin discusses the use of RSV vaccines in older adults: recommendations of the advisory committee on immunization practices, case report of leprosy in Central Florida, blood group A enhances SARS-CoV-2 infection,... by This Week in Virology